PLEASANTON, Calif. -- ZELTIQ, a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced that Mark Foley, President and Chief Executive Officer, is scheduled to present at the 32nd Annual J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco.
Event: J.P. Morgan Healthcare Conference
Date: January 15, 2014
Time: 3:00 p.m. PT
An audio webcast of the Company's presentation will be available by
visiting the investor relations section of ZELTIQ's web site at
www.coolsculpting.com. A replay of the presentation will be available
for 90 days.
About ZELTIQ(R) Aesthetics, Inc.
ZELTIQ is a medical technology company focused on developing and
commercializing products utilizing its proprietary controlled-cooling
technology platform. ZELTIQ's first commercial product, the
CoolSculpting System, is designed to selectively reduce stubborn fat
that may not respond to diet or exercise. CoolSculpting is based on the
scientific principle that fat cells are more sensitive to cold than the
overlying skin and surrounding tissues. It utilizes patented technology
of precisely controlled cooling to reduce the temperature of fat cells
in the treated area, which is intended to cause fat cell elimination
through a natural biological process known as apoptosis. ZELTIQ
developed CoolSculpting to safely, noticeably, and measurably reduce
the fat layer.
Barriers to Infection: Rethinking Mattress Cleaning
Over 1 Million Individuals Affected in Community Health Center Data Breach
Prospect Medical Holdings to Sell Crozer Health to Non-Profit Consortium
The Top States for Pest Infestations
Ground Broken on Wichita Biomedical Campus Project